Cargando…
High-dose intravenous immunoglobulin therapy for novel coronavirus disease 2019: a brief report of two cases
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481541/ http://dx.doi.org/10.1186/s42077-020-00089-4 |
_version_ | 1783580626441469952 |
---|---|
author | Erdogan, Cem Ciftci, Bahadir Kizilaslan, Deniz Ekinci, Mursel İptec, Gülsen Gemici, Ali İhsan Karaaslan, Pelin |
author_facet | Erdogan, Cem Ciftci, Bahadir Kizilaslan, Deniz Ekinci, Mursel İptec, Gülsen Gemici, Ali İhsan Karaaslan, Pelin |
author_sort | Erdogan, Cem |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7481541 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-74815412020-09-10 High-dose intravenous immunoglobulin therapy for novel coronavirus disease 2019: a brief report of two cases Erdogan, Cem Ciftci, Bahadir Kizilaslan, Deniz Ekinci, Mursel İptec, Gülsen Gemici, Ali İhsan Karaaslan, Pelin Ain-Shams J Anesthesiol Letter to the Editor Springer Berlin Heidelberg 2020-09-10 2020 /pmc/articles/PMC7481541/ http://dx.doi.org/10.1186/s42077-020-00089-4 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Letter to the Editor Erdogan, Cem Ciftci, Bahadir Kizilaslan, Deniz Ekinci, Mursel İptec, Gülsen Gemici, Ali İhsan Karaaslan, Pelin High-dose intravenous immunoglobulin therapy for novel coronavirus disease 2019: a brief report of two cases |
title | High-dose intravenous immunoglobulin therapy for novel coronavirus disease 2019: a brief report of two cases |
title_full | High-dose intravenous immunoglobulin therapy for novel coronavirus disease 2019: a brief report of two cases |
title_fullStr | High-dose intravenous immunoglobulin therapy for novel coronavirus disease 2019: a brief report of two cases |
title_full_unstemmed | High-dose intravenous immunoglobulin therapy for novel coronavirus disease 2019: a brief report of two cases |
title_short | High-dose intravenous immunoglobulin therapy for novel coronavirus disease 2019: a brief report of two cases |
title_sort | high-dose intravenous immunoglobulin therapy for novel coronavirus disease 2019: a brief report of two cases |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481541/ http://dx.doi.org/10.1186/s42077-020-00089-4 |
work_keys_str_mv | AT erdogancem highdoseintravenousimmunoglobulintherapyfornovelcoronavirusdisease2019abriefreportoftwocases AT ciftcibahadir highdoseintravenousimmunoglobulintherapyfornovelcoronavirusdisease2019abriefreportoftwocases AT kizilaslandeniz highdoseintravenousimmunoglobulintherapyfornovelcoronavirusdisease2019abriefreportoftwocases AT ekincimursel highdoseintravenousimmunoglobulintherapyfornovelcoronavirusdisease2019abriefreportoftwocases AT iptecgulsen highdoseintravenousimmunoglobulintherapyfornovelcoronavirusdisease2019abriefreportoftwocases AT gemicialiihsan highdoseintravenousimmunoglobulintherapyfornovelcoronavirusdisease2019abriefreportoftwocases AT karaaslanpelin highdoseintravenousimmunoglobulintherapyfornovelcoronavirusdisease2019abriefreportoftwocases |